Transforming growth factor-β and ischemic brain injury

Cellular and Molecular Neurobiology

Volumn 23, Issue 4-5, 2003, Pages 539-550

  Buisson, Alain ^a   Lesne, Sylvain ^a   Docagne, Fabian ^a   Ali, Carine ^a   Nicole, Olivier ^a   MacKenzie, Eric T ^a   Vivien, Denis ^a  

^a UNIVERSITÉ DE CAEN   (France)

Author keywords

Cerebral ischemia; Molecular; TGF

Indexed keywords

ALTEPLASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN BAD; STAUROSPORINE; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; ASTROCYTE; BLOOD CLOT LYSIS; BRAIN INJURY; BRAIN ISCHEMIA; CELL DEATH; HUMAN; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; STROKE;

ANIMALS; APOPTOSIS; BCL-ASSOCIATED DEATH PROTEIN; BRAIN INFARCTION; BRAIN ISCHEMIA; CARRIER PROTEINS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; NEUROPROTECTIVE AGENTS; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 0042818294     PISSN: 02724340     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1025072013107     Document Type: Review

References (53)

1. Ali, C., Nicole, O., Docagne, F., Lesné, S., MacKenzie, E. T., Buisson, A., and Vivien D. (2000). Ischemia-induced interleukin-6 as a potential endogenous neuroprotective cytokine against NMDA receptor-mediated excitotoxicity in the brain. J. Cereb. Blood Flow Metab. 20:956-966.
2. Artavanis-Tsakonas, S., Rand, M. D., and Lake, R. (1999). Notch signaling: Cell fate control and signal integration in development. Science 284:770-776.
3. Boldin, M. P., Goncharov, T. M., Goltsev, Y. V., and Wallach, D. (1996). Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell 85:803-815.
4. Buisson, A., Nicole, O., Docagne, F., Sartelet, H., MacKenzie, E. T., and Vivien, D. (1998). Up-regulation of a serine protease inhibitor in astrocytes mediates the neuroprotective activity of transforming growth factor β1. FASEB J. 12:1683-1691.
5. Cataldo, A. M., Barnett, J. L., Pieroni, C., and Nixon, R. A. (1997). Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer's disease: Neuropathologic evidence for a mechanism of increased β-amyloidogenesis. J. Neurosci. 17:6142-6151.
6. Choi, D. W. (1992). Excitotoxic cell death. J. Neurobiol. 23:1261-1276.
7. Docagne, F., Nicole, O., Marti, H. H., MacKenzie, E. T., Buisson, A., and Vivien D. (1999). Transforming growth factor-β1 as a regulator of the serpins/t-PA axis in cerebral ischemia. FASEB J. 13:1315-1324.
8. Feuerstein, G. Z., Wang, X., and Baronne, E C. (1998). The role of cytokines in the neuropathology of stroke and neurotrauma. Neuroimmunomodulation 5:143-159.
9. Fiumelli, H., Jabaudon, D., Magistretti, P. J., and Martin, J. L. (1999). BDNF stimulates expression, activity and release of tissue-type plasminogen activator in mouse cortical neurons Eur. J. Neurosci. 11:1639-1646.
10. Flanders, K. C., Lippa, C. F., Smith, T. W., Pollen, D. A., and Sporn, M. B. (1995). Altered expression of transforming growth factor-β in Alzheimer's disease. Neurology 45:1561-1569.
11. Flanders, K. C., Ren, R. F., and Lippa, C. E (1998). Transforming growth factor-βs in neurodegenerative disease. Prog. Neurobiol. 54:71-85.
12. Frautschy, S. A., Horn, D. L., Sigel, J. J., Harris-White, M. E., Mendoza, J. J., Yang, F., Saido, T. C., and Cole, G. M. (1998). Protease inhibitor coinfusion with amyloid β-protein results in enhanced deposition and toxicity in rat brain. J. Neurosci. 18:8311-8321.
13. Henrich-Noack, P., Prehn, J. H., and Krieglstein, J. (1996). TGF-β1 protects hippocampal neurons against degeneration caused by transient global ischemia. Dose-response relationship and potential neuroprotective mechanisms. Stroke 27:1609-1614.
14. Hill, I. E., Preston, E., Monette, R., and MacManus, J. P. (1997). A comparison of cathepsin-B processing and distribution during neuronal death in rats following global ischemia or decapitation necrosis. Brain Res. 751:206-216.
15. Joutel, A., Corpechot, C., Ducros, A., Vahedi, K., Chabriat, H., Mouton, P., Alamowitch, S., Domenga, V., Cecillion, M., Marechal, E., Maciazek, J., Vayssiere, C., Cruaud, C., Cabanis, E. A., Ruchoux, M. M., Weissenbach, J., Bach, J. F., Bousser, M. G., and Tournier-Lasserve, E. (1996). Notch3-mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 383:707-710.
16. Kaufmann, S. H., and Hengartner, M. O. (2001). Programmed cell death: Alive and well in the new millennium. Biology, 11:526-534.
17. Krupinski, J., Kumar, P., Kumar, S., and Kaluza, J. (1996). Increased expression of TGF-β1 in brain tissue after ischemic stroke in humans. Stroke 27:852-857.
18. Lee, J. M., Zipfel, G. J., and Choi, D. W. (1999). The changing landscape of ischaemic brain injury mechanisms. Nature 399 (6738, Suppl):A7-1.
19. Lehrmann, E., Kiefer, R., Christensen, T., Toyka, K. V., Zimmer, J., Diemer, N. H., Hartung, H. P., and Finsen, B. (1998). Microglia and macrophages are major sources of locally produced transforming growth factor-β1 after transient middle cerebral artery occlusion in rats. Glia 24:437-448.
20. Lesné, S., Blanchet, S., Docagne, F., Liot, G., Plawinski, L., MacKenzie E. T., Auffray, C., Buisson, A., Piétu, G., and Vivien, D. (2002). Transforming growth factor-β1-modulated cerebral gene expression. J. Cereb. Blood Flow Metab. 22:1114-1123.
21. Lippa, C. F., Smith, T. W., and Flanders, K. C. (1995). Transforming growth factor-β: Neuronal and glial expression in CNS degenerative diseases. Neurodegeneration 4:425-432.
22. Massagué, J. (2000). How cells read TGF-beta signals. Nat. Rev. Mol. Cell Biol. 1:169-178.
23. Massague, J., and Wotton, D. (2000). Transcriptional control by the TGF-β/Smad signaling system. EMBO J. 19:1745-1754.
24. Muzio, M., Chinnaiyan, A. M., Kischkel, F. C., O'Rourke, K., Shevchenko, A., Ni, J., Scaffidi, C., Bretz, J. D., Zhang, M., Gentz, R., Mann, M., Krammer, P. H., Peter, M. E., and Dixit, V. M. (1996). FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85:817-827.
25. Muzio, M., Stockwell, B. R., Stennicke, H. R., Salvesen, G. S., and Dixit, D. M. (1998). An induced proximity model for caspase-8 activation. J. Biol. Chem. 273:2926-2930.
26. Nagai, N., De Mol, M., Lijnen, H. R., Carmeliet, P., and Collen, D. (1999). Role of plasminogen system components in focal cerebral ischemic infarction: A gene targeting and gene transfer study in mice. Circulation 99:2440-2444.
27. National Institute of Neurological Diisorders and Stroke rt-PA Stroke Study Group (1995). Tissue plasminogen activator for acute ischemic stroke. N. Engl. J. Med. 333(24):1581-1587.
28. Nicole, O., Docagne, F., Ali, C., Margaill, I., Carmeliet, P., MacKenzie E. T., Vivien D., and Buisson, A. (2001). The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling. Nat Med. 7:59-64.
29. Nunez, G., and del Peso, L. (1998). Linking extracellular survival signals and the apoptotic machinery. Curr. Opin. Neurobiol. 8:613-618.
30. Peter, M. E., and Krammer, P. H. (1998). Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis. Curr., Opin. Immunol. 10:545-551.
31. Pinkoski, M. J., and Green, D. R. (1999). Fas ligand, death gene. Cell Death Differ. 6:1174-1181.
32. Prehn, J. H., Backhauss, C., and Krieglstein, J. (1993). Transforming growth factor-β1 prevents glutamate neurotoxicity in rat neocortical cultures and protects mouse neocortex from ischemic injury in vivo. J. Cereb. Blood Flow Metab. 3:521-525.
33. Prehn, J. H., Bindokas, V. P., Marcuccilli, C. J., Krajewski, S., Reed, J. C., Miller, R. J. (1994). Regulation of neuronal Bcl2 protein expression and calcium homeostasis by transforming growth factor type-β confers wide-ranging protection on rat hippocampal neurons. Proc. Natl. Acad. Sci. U.S.A. 91:12599-12603.
34. Prehn, J. H., and Miller, R. J. (1996). Opposite effects of TGF-β 1 on rapidly- and slowly-triggered excitotoxic injury. Neuropharmacology 35:249-256.
35. Raff, M. C., Barres, B. A., Burne, J. F., Coles, H. S., Ishizaki, Y., Jacobson, M. D. (1993). Programmed cell death and the control of cell survival: Lessons from the nervous system. Science 262:695-700.
36. Rogister, B., Leprince, P., Delree, P., Van Damme, J., Billiau, A., and Moonen, G. (1990). Enhanced release of plasminogen activator inhibitor(s) but not of plasminogen activators by cultured rat glial cells treated with interleukin-1 Glia 3:252-257.
37. Rogister, B., Leprince, P., Pettmann, B., Labourdette, G., Sensenbrenner, M., and Moonen, G. (1988). Brain basic fibroblast growth factor stimulates the release of plasminogen activators by newborn rat cultured astroglial cells. Neurosci. Lett. 91:321-326.
38. Rosenbaum, D. M., Gupta, G., D'Amore, J., Singh, M., Weidenheim, K., Zhang, H., and Kessler, J. A. (2000). Fas (CD95/APO-1) plays a role in the pathophysiology of focal cerebral ischemia. J. Neurosci. Res. 61:686-692.
39. Ruocco, A., Nicole, O., Docagne, F., Ali, C., Chazalviel L., Komesli, S., Yablonsky, F., Roussel, S., MacKenzie, E. T., Vivien, D., and Buisson, A. (1999). A transforming growth factor-beta antagonist unmasks the neuroprotective role of this endogenous cytokine in excitotoxic and ischemic brain injury. J. Cereb. Blood Flow Metab. 19:1345-1353.
40. Schneider, P., and Tschopp, J. (2000). Apoptosis induced by death receptors. Pharm. Acta. Helv. 74:281-286.
41. Segal, R. A., and Greenberg, M. E. (1996). Intracellular signaling pathways activated by neurotrophic. Neurosci. 19:463-489.
42. Selkoe, D. J. (2000). Notch and presenilins in vertebrates and invertebrates: Implications for neuronal development and degeneration. Curr. Opin. Neurobiol. 10:50-57.
43. Stennicke, H. R., Jurgensmeier, J. M., Shin, H., Deveraux, Q., Wolf, B. B., Yang, X., Zhou, Q., Ellerby, H. M., Ellerby, L. M., Bredesen, D., Green, D. R., Reed, J. C., Froelich, C. J., and Salvesen, G. S. (1998). Pro-caspase-3 is a major physiologic target of caspase-8. J. BioL Chem. 273:27084-27090.
44. Tamura, A., Graham, D. I., McCulloch, J., and Teasdale, G. M. (1981). Focal cerebral ischaemia in the rat: 2. Regional cerebral blood flow determined by [14C]iodoantipyrine autoradiography following middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 1:61-69.
45. Tsirka, S. E., Gualandris, A., Amaral, D. G., and Strickland, S. (1995). Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator. Nature 377:340-344.
46. Tsirka, S. E., Rogove, A. D., Bugge, T. H., Degen, J. L., and Strickland, S. (1997). An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus. J. Neurosci. 17:543-552.
47. Wang, Y. F., Tsirka, S. E., Strickland, S., Stieg, P. E., Soriano, S. G., and Lipton, S. A. (1998). Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice. Nat. Med. 4:228-231.
48. Weinmaster, G. (1997). The ins and outs of notch signaling. Mol. Cell. Neurosci. 9:91-102.
49. Westerhausen, D. R., Hopkins, W. E., and Billadello, J. J. (1991). Multiple transforming growth factor-beta-inducible elements regulate expression of the plasminogen activator inhibitor type-1 gene in Hep G2 cells. J. Biol. Chem. 266:1092-1100.
50. Wiessner, C., Gehrmann, J., Lindholm, D., Topper, R., Kreutzberg, G. W., and Hossmann, K. A. (1993). Expression of transforming growth factor-β 1 and interleukin-1β mRNA in rat brain following transient forebrain ischemia. Acta Neuropathol. (Berl.) 86:439-446.
51. Yuan, J., and Yankner, B. A. (2000). Apoptosis in the nervous system. Nature 12(407):802-809.
52. Zhu, Y., Culmsee, C., Roth-Eichhorn, S., and Krieglstein, J. (2001). Beta(2)-adrenoceptor stimulation enhances latent transforming growth factor-β-binding protein-1 and transforming growth factor-beta1 expression in rat hippocampus after transient forebrain ischemia. Neuroscience 107(4):593-602.
53. Zhu, Y., Yang, G. Y., Ahlemeyer, B., Pang, L., Che, X. M., Culmsee, C., Klumpp, S., and Krieglstein, J. (2002). Transforming growth factor-β1 increases bad phosphorylation and protects neurons against damage. J. Neurosci. 22:3898-3909.